Part of the conference agenda is to bring together policymakers and academic leaders to help overcome the institutional and ecosystem barriers that currently impede the smooth proliferation of the latest scientific knowledge in . Collaboration at a high level, as can be seen in some of the largest commercial and non-commercial research institutions in the world, and at a more widespread level, particularly in developed nation.
The ICDIMMC-24 intends to put an end to these long-term effects, for - the securement of the future of Diagnosis in Internal Medicine and Medical Care, this conference firmly intends to create and foster the engagement of professionals on a global scale. Participants are guaranteed to benefit from the highly illuminating lectures, insightful discussions, informative panel discussions, enlightening presentations, as well as instructive and informative workshops, and more.
1.
Combination Treatment May Improve Multiple Myeloma Outcomes
2.
Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era
3.
Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.
4.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
5.
Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer
1.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
2.
Preventing Childhood Platelet Functional Imbalance: A Comprehensive Clinical Review
3.
Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions
4.
The Science Behind Thrombolytic Drugs and Their Benefits
5.
Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
2.
Understanding the Role of Screening in Cancer Prevention
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
Recommended News For You
1.
Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer
2.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
3.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven
Conferences That Might Interest You
Recommended Articles For You
1.
Surgical Innovation Using Hematopoietic Reserve Preservation During Major Surgery
2.
Programmable Cell Therapies for Selective Removal of Dysfunctional Hematopoietic Cell Populations
3.
Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring
4.
Gene Therapy for Hemophilia: A New Hope on the Horizon
5.
A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy
Boost Your Knowledge With These Quizzes
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation